Psychedelic highlights | July 12 – 16

Shares :

Psychedelic highlights | July 12 – 16

Here is a summary of the news from the last week in the psychedelics market. The value of the psychedelics market is more than $100 billion according to Cannacord most recent report.

Psychedelic market value by company

Last week performance

Field TripFTRP$7.35+ 11 %
Revive TherapeuticsRVV$0.58+ 9.4 %
Cybin Inc. CYBN$3.54+ 7.6 %
Mind CureMCUR$0.47+ 6.8 %
M2Bio SciencesWUHN$0.454+ 4.3 %
NuminusNUMI$1.05+ 2.9 %
Red Light HollandsTRIP$0.275– 3.5 %
CompassCMPS$35.02– 4.4 %
Psyched WellnessPSYC$0.20– 4.7 %
MindMedMMED$4.05– 7.5 %
Psykey inc.CEOS$0.083– 8.3 %

Story of the week

1. Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 [news release]

Revive Therapeutics provide an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

Read the full news HERE

2. Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD [news release]

Numinus announce that Health Canada has cleared the MAPS-sponsored single-arm, open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder (PTSD). This study is being pursued in collaboration with MAPS Public Benefit Corporation (MAPS PBC).

Read the full news HERE

3. MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound [news release]

Mind Cure  announces the filing of provisional patent applications with the United States Patent and Trademark Office (USPTO) for innovative processes for synthesizing ibogaine.

Read the full news HERE

4. Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy [news release]

Cybin announced that it has filed its 13th new provisional patent application and has advanced the build-out of its digital therapeutics strategy.

Read the full news HERE

5. Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board [news release]

Lobe Sciences announce the appointment of Gilberto Jesús Mendoza, President of the World Boxing Association, to its Advisory Board.

Read the full news HERE

6. Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer [news release]

Dr. Glazer became the Medical Director for Bariatrics at Humber River Hospital in Toronto. He sits on the board for the Ontario Bariatric Network, as well as on multiple committees. He is also the President of the Canadian Association of Bariatric Physicians and Surgeons.

Read the full news HERE

7. Core One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements [news release]

Core One Labs  announce that it is pursuing a listing on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) to enhance the Company’s investor profile and increase value for its shareholders. 

Read the full news HERE

8. Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs to Six More Smart Shops and Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc [news release]

Red Light Holland’s  provide an update on the distribution of its Red Light Holland truffle farm and iMicrodose Packs in the Netherlands.

And more, Red Light Holland’s announce that Creso Pharma Ltd. (“Creso Pharma“) has completed its previously announced acquisition of Halucenex Life Sciences Inc. (“Halucenex“).

Read the full news HERE

Sign up for MORE news updates !

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.

Click on a star to rate this article !

Average rating 5 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

Shares :